Supplemental appendix for Differential risk of immunogenicity during Infliximab therapy across Hidradenitis suppurativa and other Chronic Inflammatory Diseases: A Retrospective monocentric cohort
Published: 30 January 2025| Version 2 | DOI: 10.17632/vdkr8vhsx3.2
Contributors:
Camille BARRAL, , , , , Christina Bergqvist, , Mathieu Uzzan, Description
Supplemental appendix for the brief report : "Differential risk of immunogenicity during Infliximab therapy across Hidradenitis suppurativa and other Chronic Inflammatory Diseases: A Retrospective monocentric cohort" published in the JAAD
Files
Categories
Dermatology, Immunogenicity, Inflammatory Disorder, Hidradenitis Suppurativa